Clinical Trial Update: Peanut Epicutaneous Phase II Immunotherapy Clinical Trial [Phase 2]

View source ↗

Summary

Phase II immunotherapy trial exploring peanut epicutaneous immunotherapy for peanut hypersensitivity has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Hypersensitivity
• Peanut Hypersensitivity

Drugs mentioned

• peanut epicutaneous immunotherapy (EPIT)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Peanut Hypersensitivity, Food Hypersensitivity | Phase 2 | Status: COMPLETED | Results posted: 2016-08-26